USE OF GM-CSF (LEUKINE(R) SARGRAMOSTIM) AS A CHEMOPROTECTANT PRIOR TO IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - PRELIMINARY-RESULTS OF A RANDOMIZED, CONTROLLED TRIAL

被引：0
|
作者：
PERKINS, JB [1 ]
FIELDS, KK [1 ]
ELFENBEIN, GJ [1 ]
BALLESTER, OF [1 ]
GOLDSTEIN, SC [1 ]
HIEMENZ, JW [1 ]
ZORSKY, PE [1 ]
机构：
[1] UNIV S FLORIDA,H LEE MOFFITT CANC CTR,DIV BONE MARROW TRANSPLANTAT,TAMPA,FL 33620
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A585 / A585
页数：1
相关论文
共 12 条
  • [1] Use of GM-CSF in pulmonary tuberculosis patients: preliminary results of a randomized clinical trial
    Pedral-Sampaio, DB
    Netto, EM
    Bandeira, AC
    Guerra, C
    Barberino, MG
    Hayes, A
    Badaro, R
    Agosti, J
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 312 - 312
  • [2] GM-CSF TREATMENT OF MYELODYSPLASTIC SYNDROMES - PERSONAL-EXPERIENCE AND PRELIMINARY-RESULTS OF A RANDOMIZED INTERNATIONAL STUDY
    COIFFIER, B
    BASTION, Y
    FELMAN, P
    TIGAUD, JD
    BRYON, PA
    PATHOLOGIE BIOLOGIE, 1991, 39 (09): : 957 - 958
  • [3] PRELIMINARY-RESULTS OF A PHASE-I TRIAL OF PIXY321 FOLLOWING IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) IN CHILDREN WITH RECURRENT SOLID TUMORS
    CAIRO, MS
    WEINTHAL, J
    GARRISON, L
    SENDER, L
    BAUER, M
    KRAILO, M
    BLAZAR, B
    REAMAN, G
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 703 - 703
  • [4] GM-CSF (SARGRAMOSTIM) TREATMENT IN WOMEN WITH RECURRENT IMPLANTATION FAILURE UNDERGOING TRANSFER OF SINGLE HEALTHY BLASTOCYST AFTER PGS: A RANDOMIZED CONTROLLED TRIAL.
    Scarpellini, F.
    Sbracia, M.
    FERTILITY AND STERILITY, 2018, 110 (04) : E90 - E91
  • [5] Randomized trial of early versus delayed GM-CSF with Campath-1H: Preliminary feasibility and correlative biologic studies results.
    Flinn, IW
    Sickler, J
    Lucas, M
    Buj, V
    Waymer, S
    Shinn, C
    Shabooti, M
    Flynn, J
    Diehl, L
    Byrd, JC
    BLOOD, 2000, 96 (11) : 838A - 838A
  • [6] A COMPARISON OF G-CSF EXPRESSION AND PRODUCTION BETWEEN NEWBORNS (NB) AND ADULTS AND PRELIMINARY-RESULTS OF A RANDOMIZED PLACEBO CONTROLLED TRIAL OF RHG-CSF IN NEWBORNS WITH PRESUMED SEPSIS
    GILLAN, E
    SUEN, Y
    CHRISTENSEN, R
    CAIRO, MS
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 773 - 773
  • [7] Granulocyte-macrophage colony stimulating factor (GM-CSF, Sargramostim/Immunex Corp.) after T-cell-depleted allogeneic BMT for myelodysplastic syndromes (MDS): Preliminary results of a phase II trial.
    O'Donnell, PV
    Gladsone, D
    Noga, SJ
    Jones, RJ
    BLOOD, 2000, 96 (11) : 356B - 356B
  • [8] WHAT INCREMENT OF CHEMOTHERAPY DOSE CAN BE ACHIEVED BY GM-CSF SUPPORT VS PLACEBO - RESULTS OF A RANDOMIZED DOUBLE-BLIND DOSEFINDING TRIAL ESCALATING ETOPOSIDE WITHIN THE DEXABEAM REGIMEN IN HODGKINS LYMPHOMA
    PFREUNDSCHUH, M
    HASENCLEVER, D
    LOEFFLER, M
    EHNINGER, G
    KIRCHNER, H
    KOCH, P
    SCHMITZ, N
    LATHAN, B
    RUEFFER, U
    SEXTRO, M
    FRANKLIN, J
    TESCH, H
    DIEHL, V
    BLOOD, 1994, 84 (10) : A166 - A166
  • [9] Intermittent Sargramostim Administration Expands Proliferating Naive T Cells, Tregs, HLADR+ PD-L1+Monocytes and Myeloid-Derived Suppressor Cells: Results from a Randomized Placebo-Controlled Clinical Trial of GM-CSF in Patients with Peripheral Artery Disease
    Rahbar, Alireza
    Hossain, Mohammad S.
    Giver, Cynthia R.
    Desai, Shivang
    Haroun, Yazan
    Kauser, Tanveer
    Ejaz, Kiran
    Quyyumi, Arshed A.
    Waller, Edmund K.
    BLOOD, 2023, 142
  • [10] Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)
    X Thomas
    P Fenaux
    H Dombret
    S Delair
    F Dreyfus
    H Tilly
    A Vekhoff
    P Cony-Makhoul
    V Leblond
    X Troussard
    C Cordonnier
    T de Revel
    M Simon
    F Nicolini
    AM Stoppa
    M Janvier
    D Bordessoule
    P Rousselot
    M Ffrench
    JP Marie
    E Archimbaud
    Leukemia, 1999, 13 : 1214 - 1220
12